Breaking News

Gilead, Mylan Partner for Branded Products in India

Mylan to market and distribute HIV therapies

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Mylan’s India-based subsidiary, Mylan Pharmaceuticals Private Ltd., has been named an exclusive business partner for Gilead Sciences’ branded medicines in India. Mylan will market and distribute Gilead’s HIV therapies Viread, including its indication for chronic hepatitis B virus (HBV) infection, Truvada, and Stribild, as well as AmBisome, a treatment for life-threatening, systemic fungal infections, and visceral leishmaniasis, a parasitic disease. Mylan will also manage regulatory and pha...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters